from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2752c/-

LFCtreatmentdescriptionclass of inhibitor

-1.130

Amikacinug/mL Amikacintranslation

-2.533

Cap5-10ug/mL Capreomycintranslation

-1.769

Rox10-50 ug/mL Roxithromycintranslation

-0.425

SM2-5 ug/mL Streptomycintranslation

-1.185

Tet5-10 ug/mL Tetracyclinetranslation

0.774

Rif0.2-5ug/mL Rifampicintranscription

0.038

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.673

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.368

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.221

CPZ10-50 ug/mL Chlorpromazinerespiration

1.063

Clofazimine10-13 ug/mL Clofaziminerespiration

0.280

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.358

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.780

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.019

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.396

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.439

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.430

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.515

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.981

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.786

KCN5-20 ug/mL Potassium cyaniderespiration

0.937

NaN30.2-2 mM Sodium aziderespiration

-0.002

Nigericin50 uM Nigericinrespiration

0.423

TRC10-150 ug/mL Triclosanrespiration

0.102

TRZ10-25 ug/mL Thioridazinerespiration

-3.240

Valinomycin0.5-10 uM Valinomycinrespiration

-1.044

ZnSO42 mM ZnSO4respiration

0.339

menadione6-10 ug/mL Menadionerespiration

0.011

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.379

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.323

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.235

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.640

NRP_1Non-replicating persistence stage 1dosRassociated

0.040

Amp0.2mg/mL AmpicillincellWall

-0.207

Cephalexin20-100 ug/mL CephalexincellWall

-0.508

Cerulenin0.32-5 ug/mL CerulenincellWall

0.148

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.259

EMB10-20 ug/mL EthambutolcellWall

-0.102

Eta12-40 ug/mL EthionamidecellWall

-0.252

INH0.2-0.4 ug/mL IsoniazidcellWall

0.055

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.300

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.486

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.036

BZA0.12 mg/mL BenzamidearomaticAmides

0.116

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.572

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.063

H2O24 mM hydrogen peroxideDNAdamaging

-0.427

Levo10 ug/mL LevofloxacinDNAdamaging

0.229

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.152

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.192

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.180

UVUV-irradiationDNAdamaging

-0.703

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.622

Antimycin12.5-50 ug/mL Antimycin A?

-0.741

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.251

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.212

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.815

PA8240.2-2 ug/mL PA-824?

0.642

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.240

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.203

Verapamil50 uM Verapamil?

-0.609

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.354

methoxatin10-20 ug/mL Methoxatin?